Free Trial
→ The next assassination attempt won’t be on Trump (From Porter & Company) (Ad) Free AVTE Stock Alerts

Aerovate Therapeutics (AVTE) SEC Filings & 10K Form

Aerovate Therapeutics logo
$2.56 -0.07 (-2.66%)
(As of 11/14/2024 ET)
Compare

Recent Aerovate Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
10/31/2024
3:55 PM		Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:55 PM		Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM		Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM		Aerovate Therapeutics (Subject)
Form 425
10/31/2024
8:27 AM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:29 AM		Aerovate Therapeutics (Subject)
Form 425
10/17/2024
3:59 PM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:04 PM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:31 PM		Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
7:00 AM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:00 PM		Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
06/20/2024
4:56 PM		Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:35 AM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:44 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:00 PM		Aerovate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
7:29 PM		Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:10 PM		Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:10 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:57 PM		Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:39 PM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:59 PM		Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
3:16 PM		Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
04/26/2024
4:23 PM		Aerovate Therapeutics (Filer)
Form ARS
04/26/2024
6:18 AM		Aerovate Therapeutics (Filer)
Form DEF 14A
04/26/2024
6:19 AM		Aerovate Therapeutics (Filer)
Form DEFA14A
04/19/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:35 PM		Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:35 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The #1 Crypto for AI (Ad)

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.
04/16/2024
3:25 PM		Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
5:00 PM		Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:42 PM		Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
6:18 PM		Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
6:24 PM		Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:31 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
8:22 AM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:15 PM		Aerovate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
3:12 PM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:35 PM		Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:37 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
2:28 PM		Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:34 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
6:09 PM		Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
Form SC 13D/A
02/20/2024
5:38 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
3:28 PM		Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
Form SC 13G
02/07/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:45 PM		Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:29 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
5:00 PM		Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:11 PM		Aerovate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
6:59 AM		Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:17 PM		Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
5:00 PM		Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM		Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)

Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…

Click here to reserve your free seat at the Crypto Community Summit
12/29/2023
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
4:50 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:24 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
5:00 PM		Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:10 PM		Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/07/2023
5:00 PM		Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:00 PM		Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:04 PM		Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AVTE) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...
True Gold Republic | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...
Colonial Metals | Sponsored
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
Musk Says ‘Dollar Will Be Worth Nothing…’
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...
Crypto 101 Media | Sponsored
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...
Weiss Ratings | Sponsored
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...
Crypto Swap Profits | Sponsored
Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
Porter & Company | Sponsored